Spray Stretch Technique Versus Sustain Pressure for Trapezius Triggers

April 11, 2022 updated by: Riphah International University

Effects of Spray and Stretch Technique Versus Sustain Pressure for the Management of Upper Trapezius Triggers

The aim of this research is to determine the effects of spray and stretch technique versus sustain pressure for the management of upper trapezius triggers. A randomized control trail is conducting at Khyber Teaching Hospital Peshawar and Northwest General Hospital and Research center Peshawar. The sample size is 54. The Participants divide into two groups, 27 participants in Group A (receive the spray and stretch technique) and 27 in Group B (receive sustain pressure). The study duration is 6 months. Purposive non probability sampling technique applied. Only 20 to 35 years participants with upper trapezius trigger is including in this trial. Tools use in this study are visual analogue scale (VAS), Neck Disability Index (NDI), Hospital Anxiety and Depression Scale (HADS), Goniometer, Algometer and Manual muscle strength (MMT). Data analyzed through SPSS version 25.

Study Overview

Detailed Description

Myofascial Trigger Point (MTrP) is a hyperirritable spot in the taut bands of the skeletal muscles' fascia which is palpable and tender, on direct compression can produce referred pain in its reference zone, local tenderness and elicit a local twitch response. MTrP can be identified as either active or latent. According to Simons et al. that active and latent trigger points are associated with tenderness, muscle dysfunction, muscle weakness and restricted muscle length. An active MTrP causes spontaneous pain complaint in surrounding tissue and generally in its pain reference zone while latent MTrP physically exist but doesn't associate with spontaneous pain complaint. However, by direct compression latent MTrP can cause local pain on the site of taut band. Myofascial trigger points (MTrP) are considered one of the most common cause of musculoskeletal pain. Active MTrP are considered to be more prevalent in upper fibers of trapezius muscle (45% in right upper trapezius and 25% in left upper trapezius and cause neck pain and shoulder discomfort. Predisposing Factors associated to MTrP can be either mechanical stress (such as overuse of muscles, repetitive strain injury, work related mechanical disorder, awkward posture and degenerative condition) or metabolic stress( such as hypo metabolic state and vitamin deficiency).According to integrated hypothesis presented by Simon, MTrP is believed to develop after a local injury either repetitive micro trauma or gross trauma to the muscle fibers. The diagnostic criteria of MTrP used by recent studies which is presented by Simons et al. is based on palpation of muscle. A well-trained clinician palpates the muscle to localize the active MTrP. During physical examination, a hyper sensitive spot within taut bands of muscle fibers, Palpation of recognized spot results in referred pain within reference zone, palpation of recognized spot elicits a jump sign (defensive movement), palpation may result in local twitch response defined as visible contraction of muscle. There are varieties of physiotherapy interventions for the management of MTrP which maybe invasive and non-invasive such as dry needling, anesthetic injections, spray and stretch, ischemic compression and muscle energy techniques. A very limited evidence found on effects of spray and stretch technique versus sustain pressure for the Management of upper trapezius trigger points with flaws in methodology design. To fill the gap, this study is formulated to determine the effects of spray and stretch technique vs sustain pressure for the management of upper trapezius MTrP. Study will find out most effective treatment for management of upper trapezius and would contribute to educate and treat the patient with most simple and effective treatment approach.

Literature review A systematic and evidence-based search of relevant literature were performed by utilizing PubMed and Google Scholar as search engines.

A study conducted in 2017 regarding spray and stretch technique versus progressive pressure release on treatment of myofascial pain trigger point reported that spray and stretch technique was more effective in increasing functional activities while progressive pressure release was more effective in decreasing pain

Another study in 2017 regarding Immediate effect of spray and stretch on trapezitis demonstrated that spray and stretch technique is effective in terms to increases range of motion and increase pain pressure threshold on acute trapezitis.

A study in 2017 found that the number of active MTrP was positively associated with the physical burden of headache and trait anxiety.

Study in 2013 concluded that Vapocoolant spray may be more effective than ice as an analgesic for IV insertion. Subjects were more satisfied with vapocoolant spray.

Another study in 2014 investigated that spray and stretch had a short-term (<6h) effect in reducing post needling soreness of a latent MTrP and Pressure pain threshold did not significantly change after spray and stretch.

Study in 2018 reported that ischemic compression and progressive sustained pressure both have significant effect on improving the pain of patients with chronic musculoskeletal pain pathologies.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • KPK
      • Peshawar, KPK, Pakistan, 25000
        • Northwest General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least one active myofascial trigger point in upper trapezius muscle.
  • Painful limitation of neck lateral flexion range to opposite side of affected muscle.

Exclusion Criteria:

  • Participants with pain pattern which is similar to pain of trigger point due to any other reason not related myofascial trigger points.
  • Any trauma to cervical spine (whiplash injury) or any cervical spine surgery.
  • Cervical myeloma, complex regional pain syndrome, thoracic outlet syndrome.
  • Cervical radiculopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Spray and Stretch technique Conventional treatment Hot pack (10-15 min) Stretching (3 sets of 10 repetitions with 10 seconds hold) AROM exercises (3 sets of 10 repetition)

Group A receive spray and stretch technique (Ethyl chloride) with conventional treatment.

The upper trapezius muscle stretches on the basis of the Technique originally described by Simons. The subject is seated in a relaxed position on their homolateral hand for anchoring the distal end of the studied muscle. Initially, 3 to 5 parallel sweeps of ethyl chloride spray is applied covering the Upper trapezius muscle. Then, the muscle are positioned in a maximal but tolerable stretch and lengthened until the Physical Therapist felt the muscle tension barrier. This procedure repeated 2 or 3 times.

Active Comparator: Group B
Sustain pressure release Conventional treatment Hot pack (10-15 min) Stretching (3 sets of 10 repetitions with 10 seconds hold) AROM exercises (3 sets of 10 repetition)

Group B receive sustain pressure release with conventional treatment. Progressive pressure release are considered in two stages. The initial step is to recognize and find the trigger in upper fiber of trapezius, utilizing trigger point palpation. Trigger point felt as firm and restricted hyperirritable knots with in gut of the muscle.

The second step is to applying pressure release ranging from eight to twelve second for each pressure, then it increases gradually for maximum of twenty seconds. The total duration of pressure is five minutes or more until the discharge is felt by the fingers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neck disability index
Time Frame: 2 weeks
Changes from base line Northwick disability index was developed first in Northwick Park hospital, England. It was designed to measure the neck pain and disability over time. It consists of 10, five parts sections. At the end, score is calculated by dividing the obtained score by total (50) multiplied by 100.
2 weeks
Pressure Pain Threshold (PPT)
Time Frame: 2 weeks
Changes from the Baseline Pressure Pain Threshold (PPT) will taken with the help of Algometer
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue scale(VAS)
Time Frame: 2 weeks
Changes from base Line Visual Analogue scale is a scale for pain starting from 0-10. where 0 indicate no pain and 10 indicate severe pain
2 weeks
Range Of Motion of cervical
Time Frame: 2 weeks
Changes from the Baseline range of Motion of cervical spine will take with the Help of Goniometer
2 weeks
The Hospital Anxiety and Depression Scale (HADS)
Time Frame: 2 weeks
HADS is a valid and reliable self-rating scale that measures anxiety and depression in both hospital and community settings. The HADS is a fourteen-item scale. Seven of the items relate to anxiety and seven relate to depression.The "0-7" score indicates normal condition,"8-10" score indicates boarderline case and "11-21" score indicates the abnormal case.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr Saira Waqqar, PP-DPT,MHPE, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2020

Primary Completion (Actual)

March 15, 2021

Study Completion (Actual)

March 31, 2021

Study Registration Dates

First Submitted

September 16, 2020

First Submitted That Met QC Criteria

September 16, 2020

First Posted (Actual)

September 23, 2020

Study Record Updates

Last Update Posted (Actual)

April 15, 2022

Last Update Submitted That Met QC Criteria

April 11, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trigger Point Pain, Myofascial

Clinical Trials on Spray and Stretch technique (Ethyl chloride)

3
Subscribe